InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,652.00
(
0.06%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,788.29
(
-0.01%
)
Post# of 4094
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

pointofreturn

Send PM Follow Ignore
Followers 21
Posts 580
Boards Moderated 0
Alias Born 01/21/2011

pointofreturn

Re: None

Wednesday, 01/28/2015 12:39:14 PM

Wednesday, January 28, 2015 12:39:14 PM

Post# of 4094
Simple business model - Vanc sources drugs that have already obtained FDA equivalent approvals through affiliated companies in China and India, in exchange for manufacturing rights when the drugs are approved by Health Canada.

This has been quarterbacked by CEO Arun Nayyar, who has an extensive track record in the generics industry, having held executive positions with pharma companies in Latin America, Asia, and Canada and has played an instrumental role opening up new markets abroad
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up